Anorectal gastrointestinal stromal tumor: a rare case report
DOI:
https://doi.org/10.18203/2349-2902.isj20242464Keywords:
GIST, Mesenchymal tumor, Anorectal tumor, ImatinibAbstract
A gastrointestinal stromal tumor (GIST) is a mesenchymal tumor of gastrointestinal tract arising from the interstitial cell of Cajal with rare occurrence in anorectum. Mutations of c-KIT proto-oncogene characterized by the expression of the KIT (CD-117) tyrosine kinase or platelet-derived growth factor receptor alpha (PDGFRα) is frequently seen with these tumours. Elderly patients with age greater than 50 are at higher risk of GIST. Here, we present a case of a 51-year-old male who presented with vague dull aching pain in the right-side perianal area since last one month with a submucosal mass in the right posterolateral wall of the anal canal and rectum. The histopathological and immunohistochemistry study of the biopsy sample reported strongly positive for CD117 and less than 3% of tumor cells showed Ki67 positivity. The patient underwent laparoscopic abdomino-perinel resection. Post-operatively, the patient was started on adjuvant imatinib with regular follow-up.
References
Mazur MT, Clark HB: Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983;7(6):507-19.
Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumours. Ann Chir Gynaecol. 1998;87(4):278-81.
Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002;3(11):655-64.
Hawkins AT, Wells KO, Krishnamurty DM, Steven RH, Matthew GM, Sean CG, et al. Preoperative chemotherapy and survival for large anorectal gastrointestinal stromal tumors: a national analysis of 333 cases. Ann Surg Oncol. 2017;24(5):1195-201.
Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003;23(2):283-304.
Souba WW, Fink MP, Jurkovich GJ, Kaiser LR, Pearce WH, Pemberton JH, et al. ACS Surgery: Principles and Practice. 6 ed. WebMD, Inc., New York. 2007.
Nilsson B, Bümming P, Meis-Kindblom JM, Anders O, Aydin D, Bengt G, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the pre imatinib mesylate era--a population-based study in western Sweden. Cancer. 2005;103(4):821-9.
Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11(8):728-34.
Yamaguchi U, Hasegawa T, Masuda T, Sekine S, Kawai A, Chuman H, et al. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch. 2004;445:142-50.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466-78.
Fletcher CD, Berman JJ, Corless C, Fred G, Jerzy L, Jack BL, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459-65.
